HYALURONIC ACID CHEEKS

The initial consultation is decisive and assesses the whole face, not just cheeks, considering volume balance, proportions and expression. Dr Romano assesses natural cheek anatomy relative to cheekbones, facial contour and nasolabial folds, alongside skin and subcutaneous tissue quality.
It precisely identifies deep fat loss, laxity, disrupted support or combined causes. Expectations are clarified : volume restoration, sagging correction or subtle enhancement. This is essential to a coherent, realistic strategy.
Full history checks contraindications, conditions, current treatments and previous procedures. Dr Romano explains the process, benefits, limitations and possible temporary effects.
A personalised plan specifies areas, estimated volumes, proposed product and, if needed, comprehensive treatment of other facial areas.

Injections are indicated when cheek volume or support changes compromise balance. The main indication is age-related loss from gradual fat compartment resorption and reduced deep support, giving less full cheeks, lost projection and midfacial sagging.
Constitutional cheek hollowing is another indication. Underdeveloped or unsupported cheeks may look angular or stern regardless of age. Measured correction improves proportions without changing natural features.
Disorganised midfacial volume also warrants treatment. Reduced support allows tissues to descend. Restoring structural support helps prevent deeper folds and laxity.
Injections may also support overall harmonisation when assessment identifies imbalance. Every indication considers anatomy, age and expectations through precise medical evaluation.

A major advantage is precise, controlled restoration in a key structural region, directly supporting the midface.
Appropriate rheological properties allow harmonious integration at deep or intermediate levels. Gradual integration gives stable correction without rigidity while preserving expressive movement.
Reversibility is another important benefit.
Volumes can be finely adjusted for gradual, personalised correction according to anatomy and tissue evolution. This flexibility supports controlled, lasting results.
Rigorous medical protocols ensure excellent tolerance. Biocompatibility and gradual degradation particularly suit cheeks, where safety and quality are crucial.

Precautions limit temporary adverse reactions. Avoid medicines increasing bleeding risk such as aspirin or certain anti-inflammatory drugs in preceding days unless medically advised otherwise.
Limit alcohol during the preceding 24 hours to reduce bruising or inflammation. Avoid blood-thinning supplements, particularly ginkgo biloba, vitamin E or high-dose omega-3.
Arrive with clean, make-up-free cheeks. Postpone harsh care such as peels, lasers or deep facial massage in preceding days.
Report recent skin infection, fever or ongoing treatment that could affect the procedure. Following instructions supports safety and result quality.

Treatment occurs in a practice meeting medical hygiene and safety standards. Careful cleansing and disinfection always precede injection to limit infection.
Depending on sensitivity and product, local anaesthesia, usually cream, may be offered. Often optional, as many products contain local anaesthetic.
Fine needles or cannulas follow the consultation plan. Slow, precise placement at targeted levels ensures even distribution with continual symmetry and volume assessment.
Small adjustments may optimise integration. The procedure is generally short, a few minutes, with comfortable positioning. Immediate visual checks precede departure.

Selection follows precise medical criteria linked to cheek anatomy and goals. Product must provide effective volume support with harmonious integration.
Sufficient cohesivity and elasticity maintain volume, especially deeply. An overly fluid gel would spread too quickly and fail to structure; an overly rigid gel could impair suppleness and movement.
Highly cross-linked gels designed for volume restoration resist mechanical forces for stable correction respecting contours.
Depth and tissue quality also guide choice. Complementary products may sometimes precisely adapt care. Rigorous selection determines safety and final quality.

Aftercare promotes integration and limits temporary reactions. Avoid deliberate manipulation in following hours, particularly firm massage or repeated cheek pressure.
Avoid intense exercise for 24 to 48 hours, as it may increase inflammation. Heat from hot baths, saunas, steam rooms or prolonged sun is discouraged for several days.
Postpone make-up at least until the next day for skin asepsis. Temporarily stop massage, salon treatments or device-based care according to Dr Romano's instructions.
Occasional indirect cooling may help tenderness or slight swelling. Follow medical instructions carefully and contact the practice for unusual or persistent reactions. This supports safe, smooth treatment.

The protocol relies on thorough midfacial anatomy knowledge and rigorous preliminary assessment. Cheeks have distinct planes differing in circulation, mobility and structural role. Depth follows goals and product.
Usually deep injection provides lasting support. Intermediate placement may complement this for smoother volume transitions or local irregularities. Gradual, controlled and even quantities are always preferred.
Points account for landmarks and vascular risks. Slow placement with constant diffusion control limits complications and optimises integration.
Follow-up may adjust the protocol according to individual response.

Filling restores volume and balance, providing appropriate support without excess projection or changed features. Softer curves and continuity with other areas restore harmony.
Cheeks become fuller but natural, respecting original anatomy. Hollowing or sagging improves while mobility and expression remain. Final results must be subtle and balanced, without freezing.
Overall perception also improves : support makes the face rested and proportionate. The eyes may look more open and transitions smoother without an identifiable correction.
Improvement appears quickly and progresses over weeks as product integrates. Success rests on naturalness and accompanying facial evolution without altered identity.

Effects vary with medical and biological factors, averaging between 10 and 12 months. Usually deep placement undergoes less repeated movement and rapid breakdown.
Highly cross-linked volumising products resist enzymatic and mechanical degradation better, retaining volume longer.
Metabolism, age, tissue quality and lifestyle influence duration. Some absorb faster, others retain results beyond average.
Absorption is gradual, with slow, even volume reduction rather than abrupt loss. Natural maintenance can accompany facial evolution rather than oppose it.

Recovery is usually straightforward and temporary. Slight tenderness, sometimes moderate swelling, commonly occurs within hours and resolves spontaneously within days.
Small injection-site bruises may occur with fragile capillaries and fade without specific care. Temporary tightness or subtle asymmetry may precede full integration.
Follow-up, usually later, checks integration, volume symmetry and absence of prolonged adverse reactions.
Recovery requires no social downtime or interruption of daily activities.

Clinical experience shows satisfaction usually concerns overall harmony rather than visible transformation of one area. At follow-up, changes are perceived as gradual and natural, preserving expression and identity.
Observations show restored midfacial volume balance, giving a more rested, harmonious face.